Skip to main content
Livermore
Livermore
ZHEN

Engineers Gate Manager LP

SEC CIK
0001620220
Latest filing
Aug 14, 2026

CPRX holding history

Catalyst Pharmaceuticals, Inc. in every 13F filed by Engineers Gate Manager LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CPRX overviewAll 13F holders of CPRXFull Q2 2026 holdings

Shares (Q2 2026)
87,867
Value
$2.76M
% of portfolio
<0.1%
Quarters held
17
Since Q1 2021
Holdings of CPRX by Engineers Gate Manager LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202687,867$2.76M<0.1%+20,806+31.0%AddedHolders
Q1 202667,061$1.66M<0.1%+18,922+39.3%AddedHolders
Q4 202548,139$1.12M<0.1%−95,525−66.5%ReducedHolders
Q3 2025143,664$2.83M<0.1%+87,522+155.9%AddedHolders
Q2 202556,142$1.22M<0.1%+56,142NewHolders
Q1 20250$00.0%−42,737−100.0%Sold outHolders
Q4 202442,737$891.9K<0.1%−4,159−8.9%ReducedHolders
Q3 202446,896$932.3K<0.1%−39,652−45.8%ReducedHolders
Q2 202486,548$1.34M<0.1%−60,407−41.1%ReducedHolders
Q1 2024146,955$2.34M0.1%+146,955NewHolders
Q4 20230$00.0%−102,731−100.0%Sold outHolders
Q3 2023102,731$1.20M<0.1%+102,731NewHolders
Q2 20230$00.0%−26,011−100.0%Sold outHolders
Q1 202326,011$431.3K<0.1%+26,011NewHolders
Q4 20220$00.0%−38,274−100.0%Sold outHolders
Q3 202238,274$491.0K<0.1%−21,965−36.5%ReducedHolders
Q2 202260,239$422.0K<0.1%+18,794+45.3%AddedHolders
Q1 202241,445$344.0K<0.1%+41,445NewHolders
Q4 20210$00.0%−15,395−100.0%Sold outHolders
Q3 202115,395$82.0K<0.1%−30,708−66.6%ReducedHolders
Q2 202146,103$265.0K<0.1%−9,963−17.8%ReducedHolders
Q1 202156,066$258.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.